高参数解析人恒定自然杀伤T细胞揭示同种免疫与自身免疫中的异质性
该研究采用高维数据驱动方法建立解析人恒定自然杀伤T(iNKT)细胞异质性的框架,发现具有不同功能的新旧iNKT细胞表型,其中HLA-II+CD161-表型与iNKT活化相关并伴随辅助性T细胞1功能,CD4-CD94+表型具有增强的细胞毒功能,二者分别与异基因造血干细胞移植后急性移植物抗宿主病及新发1型糖尿病相关。
要点
- 高维数据驱动框架可解析人iNKT细胞异质性并识别不同功能表型。
- HLA-II+CD161- iNKT细胞群随活化增加且与急性GVHD相关。
- CD4-CD94+ iNKT细胞群细胞毒功能增强且与新发1型糖尿病相关。
核心结论
- 研究识别出与人疾病相关的人iNKT细胞表型,可辅助开发生物标志物或靶向iNKT细胞的治疗。
研究设计与样本
- 采用高维、数据驱动的方法建立解析人iNKT细胞异质性的框架。
主要发现
- 发现具有辅助性T细胞1功能且随iNKT活化增加的HLA-II+CD161-表型。
- 发现细胞毒功能增强的CD4-CD94+表型。
- HLA-II+CD161-表型与异基因造血干细胞移植后急性移植物抗宿主病相关。
- CD4-CD94+表型与新发1型糖尿病相关。
临床怎么用
- 可依据HLA-II+CD161-与CD4-CD94+ iNKT表型探索急性GVHD和1型糖尿病的生物标志物。
- 可针对上述iNKT细胞表型探索靶向iNKT细胞的治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Human invariant natural killer T (iNKT) cells are a rare innate-like lymphocyte population that recognizes glycolipids presented on CD1d. Studies in mice have shown that these cells are heterogeneous and are capable of enacting diverse functions, and the composition of iNKT cell subsets can alter disease outcomes. In contrast, far less is known about how heterogeneity in human iNKT cells relates to disease. To address this, we used a high-dimensional, data-driven approach to devise a framework for parsing human iNKT heterogeneity. Our data revealed novel and previously described iNKT cell phenotypes with distinct functions. In particular, we found 2 phenotypes of interest: (1) a population with T helper 1 function that was increased with iNKT activation characterized by HLA-II+CD161- expression, and (2) a population with enhanced cytotoxic function characterized by CD4-CD94+ expression. These populations correlate with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation and with new onset type 1 diabetes, respectively. Our study identifies human iNKT cell phenotypes associated with human disease that could aid in the development of biomarkers or therapeutics targeting iNKT cells.
引用
- Erkers T, Xie BJ, Kenyon LJ, et al. High-parametric evaluation of human invariant natural killer T cells to delineate heterogeneity in allo- and autoimmunity. Blood. 2020. PMID: 31935280. doi:10.1182/blood.2019001903
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。